Antifungal susceptibility testing of Malva parviflora yield extracts, against C. albicans and A. fumigatus

Main Article Content

Bushra Dakhil
Ahmed Eshwika
Basma Doro
Rabia O Alghazeer
Ibrahim Eldaghayes
Keven kavanagh

Abstract

The increasing on the incidence of drug-resistant pathogens has drawn the attention of
researchers towards screening the antimicrobial action of plant-derived compound. This
study aimed to determine the antifungal activity of Malva parviflora extracts, which is
widespread and used by the general population in Libya. Extraction was carried out using a
cold maceration method by several different polarity solvents (petroleum ether, ethyl
acetate, methanol and distilled water). Their total-phenolic and flavonoid content were
assessed. The content of total phenolic and flavonoids were found to be the highest in
petroleum ether fraction extract (119.558mg GAEg-1) and (227.029mg RU g-1)
respectively. The antioxidant activity was estimated using DPPH as free radical scavenging
and sugar reducing power. The methanol fraction extract displayed the highest IC50 (50
mg/ml). The results indicate that the increase in the percentage of DPPH free radical
inhibition is directly proportional with the increase in the extract concentration. Reducing
power increased with the increase on extracts concentration. M. parviflora leave extracts
were tested against fungal species Aspergillus. fumigatus and Candida. albicans using
antifungal susceptibility assay of yeast and filamentous fungi. Extracts had strong
antifungal activity against C. albicans and A. fumigates. Petroleum ether fraction extract
has the strongest antifungal activity against A. fumigatus with 94.96% percentage of
inhibition. The percentage of inhibition is 96.48% was shown against C. albicans for
aqueous extract.

Article Details

How to Cite
Dakhil, B., Eshwika, A., Doro, B., Alghazeer, R. O., Eldaghayes, I., & kavanagh, K. (2023). Antifungal susceptibility testing of Malva parviflora yield extracts, against C. albicans and A. fumigatus. Academic Journal of Science and Technology, 1(1), 101–108. https://doi.org/10.64095/ajst.v1i1.42
Section
Biomedical sciences

References

EFERENCES

Caesar, L. K. and Cech, N. B. (2019) ‘Synergy and

antagonism in natural product extracts: When 1 + 1 does

not equal 2’, Natural Product Reports. doi:

1039/c9np00011a.

Ahmad, S. A. and Askari, A. A. (2015) ‘Ethnobotany of

the hawraman Region of Kurdistan Iraq’, Harvard

Papers in Botany. doi: 10.3100/hpib.v20iss1.2015.n8.

Abdallah, E. M. (2011) ‘Plants: An alternative source

for antimicrobials’, Journal of Applied Pharmaceutical

Science.

Pfaller, M. A. and Diekema, D. J. (2004) ‘Rare and

emerging opportunistic fungal pathogens: Concern for

resistance beyond Candida albicans and Aspergillus

fumigatus’, Journal of Clinical Microbiology, 42(10),

pp. 4419–4431. doi: 10.1128/JCM.42.10.4419-

2004.

CLSI (2008) ‘Reference method for broth dilution’,

Reference method for broth dilution antifungal

susceptibility testing of yeasts. Approved standard, 3th

ed., 28(14), pp. 0–13.

Vermeersch, M. et al. (2009) ‘In vitro susceptibilities

of Leishmania donovani promastigote and amastigote

stages to antileishmanial reference drugs: Practical

relevance of stage-specific differences’, Antimicrobial

Agents and Chemotherapy. doi: 10.1128/AAC.00548-

Evans, W. C. (1998) Trease and Evans

Pharamagonosy, WB Saunders and Company,

London.

Kokate, A. (1999) ‘Phytochemical Methods’, in

Phytotherapy, pp. 126–129.

Singleton V.L., Orthofer R., Lamuela-Raventos R.M.

Analysis of total phenols and other oxidation

substrates and antioxidants by means of FolinCiocalteu reagent. Method Enzymol. 1999;299:152–

Zhishen, J., Mengcheng, T. and Jianming, W. (1999)

‘The determination of flavonoid contents in mulberry

and their scavenging effects on superoxide radicals’,

Food Chemistry. doi: 10.1016/S0308-8146(98)00102-

Anand, U. et al. (2019) ‘A comprehensive review on

medicinal plants as antimicrobial therapeutics:

Potential avenues of biocompatible drug discovery’,

Metabolites. doi: 10.3390/metabo9110258.

Vermeersch, M. et al. (2009) ‘In vitro susceptibilities

of Leishmania donovani promastigote and amastigote

stages to antileishmanial reference drugs: Practical

relevance of stage-specific differences’, Antimicrobial

Agents and Chemotherapy. doi: 10.1128/AAC.00548-

Oyebode, O. et al. (2016) ‘Use of traditional medicine

in middle-income countries: A WHO-SAGE study’,

Health Policy and Planning. doi:

1093/heapol/czw022.

Pfaller, M. A. and Diekema, D. J. (2004) ‘Rare and

emerging opportunistic fungal pathogens: Concern for

resistance beyond Candida albicans and Aspergillus

fumigatus’, Journal of Clinical Microbiology, 42(10),

pp. 4419–4431. doi: 10.1128/JCM.42.10.4419-

2004.

Caesar, L. K. and Cech, N. B. (2019) ‘Synergy and

antagonism in natural product extracts: When 1 + 1

does not equal 2’, Natural Product Reports. doi:

1039/c9np00011a.

Balouiri, M., Sadiki, M. and Ibnsouda, S. K. (2016)

‘Methods for in vitro evaluating antimicrobial activity:

A review’, Journal of Pharmaceutical Analysis. doi:

1016/j.jpha.2015.11.005